Marker Therapeutics, Inc. has filed 902 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| 10-Q | 2026-05-15 | Quarterly Report |
| 8-K | 2026-05-04 | Amendments to Articles of Incorporation or Bylaws; Submission of Matters to a Vote of Security Holders |
| DEF 14A | 2026-03-20 | Proxy Statement |
| ARS | 2026-03-20 | ARS |
| DEFA14A | 2026-03-20 | Additional Proxy Soliciting Materials |
| 8-K | 2026-03-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 10-K | 2026-03-18 | Annual Report |
| PRE 14A | 2026-03-10 | PRE 14A |
| 8-K | 2026-02-09 | Shareholder Nominations Pursuant to Exchange Act Rule 14a-11; Financial Statements and Exhibits |
| 4 | 2025-11-19 | Statement of Changes in Beneficial Ownership |